bimagrumab tirzepatide Semaglutide and combination reduces fat mass 𝗕𝗶𝗺𝗮𝗴𝗿𝘂𝗺𝗮𝗯: 𝗣𝗿𝗲𝘀𝗲𝗿𝘃𝗶𝗻𝗴 𝗠𝘂𝘀𝗰𝗹𝗲 𝗠𝗮𝘀𝘀 𝗗𝘂𝗿𝗶𝗻𝗴

Science (2007) 316:88994

In contrast, our real-world cohort, without strict eligibility restrictions, may capture risk emerging in specific subpopulations

In a similar experimental model, HD significantly decreased hepatic TGF1, hydroxyproline, the serum liver function markers of ALT, AST and total bilirubin, the hepatic content of MDA and myeloperoxidase activity, the serum pro-inflammatory cytokine TNF-, relative liver weight, and the serum lipid profile markers cholesterol, triglycerides and low-density lipoprotein compared with the reference drug SL, which suggested that HD may be a promising protective agent against liver fibrosis (Abdel-Sttar et al., 2017)

Then came a host of knock-offs, unapproved alternatives, and "natural" solutions

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Body Weight Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325 (14): 14141425

The formulas are rigorously tested and optimised to deliver results, so you know if you invest in one of these three serums, you're going to see visible benefits